gene_symbol
FCGR3A
hgnc_id
HGNC:3619
binding_type
other
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Benralizumab’s afucosylated Fc engages CD16a on NK cells to induce ADCC against IL-5Rα–expressing eosinophils/basophils; CD16a+ cells are effectors, not killed.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Fc-mediated engagement for ADCC on NK cells; affinity enhanced by afucosylated Fc
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06501807
disease_id_num_tar_ref
3427
drug_id_num_tar_ref
9259